Name: Celyad Oncology SA (CYAD) Stock
Brand: Celyad Oncology SA
Rating: 2.5 (3 reviews)

CYAD Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Celyad Oncology SA

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

2 years ago - By: Celyad Oncology SA

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

2 years ago - By: Celyad Oncology SA

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

2 years ago - By: Celyad Oncology SA

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

2 years ago - By: Celyad Oncology SA

Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights

2 years ago - By: Celyad Oncology SA

Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights

2 years ago - By: Celyad Oncology SA

Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders

2 years ago - By: Celyad Oncology SA

Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders

2 years ago - By: Celyad Oncology SA

Celyad Oncology announces receipt of Nasdaq delisting notice

2 years ago - By: Benzinga - Mentions: OMI TBIO CANF SNGX ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

2 years ago - By: Seeking Alpha

Celyad plans to delist from Nasdaq amid cash woes

2 years ago - By: Celyad Oncology SA

Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq

2 years ago - By: Celyad Oncology SA

Celyad Oncology reports first quarter 2023 financial results and recent business highlights

3 years ago - By: Celyad Oncology SA

Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price

3 years ago - By: Benzinga - Mentions: IBIO BIOL MTNB BLCM ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

3 years ago - By: Celyad Oncology SA

Celyad Oncology announces receipt of Nasdaq notice

3 years ago - By: Celyad Oncology SA

Celyad Oncology appoints Georges Rawadi as its new CEO

3 years ago - By: Celyad Oncology SA

Celyad Oncology reports full year 2022 financial results and recent business highlights

3 years ago - By: Celyad Oncology SA

Celyad Oncology to announce full year 2022 financial results and host conference call

3 years ago - By: InvestorPlace - Mentions: JNCE STBX SWVL LYLT ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

3 years ago - By: Seeking Alpha

Celyad stock slumps ~30% as board to put proposal to continue activities on vote

3 years ago - By: Celyad Oncology SA

Celyad Oncology announces non-cash impairment

3 years ago - By: Celyad Oncology SA

Celyad Oncology SA (CYAD) Stock News

CYAD Latest News, Press Relases and Analysis

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights

Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights

Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders

Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders

Celyad Oncology announces receipt of Nasdaq delisting notice

12 Health Care Stocks Moving In Friday's Pre-Market Session

Celyad plans to delist from Nasdaq amid cash woes

Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq

Celyad Oncology reports first quarter 2023 financial results and recent business highlights

Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price

12 Health Care Stocks Moving In Wednesday's Intraday Session

Celyad Oncology announces receipt of Nasdaq notice

Celyad Oncology appoints Georges Rawadi as its new CEO

Celyad Oncology reports full year 2022 financial results and recent business highlights

Celyad Oncology to announce full year 2022 financial results and host conference call

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Celyad stock slumps ~30% as board to put proposal to continue activities on vote

Celyad Oncology announces non-cash impairment

Celyad Oncology SA - Letter to Shareholders